Analyst Ratings for Redhill Biopharma (RDHL)

RDHL Rating Summary

RDHL Price Target Summary

* Over Last 12-Mos
  |   Expand Research on RDHL
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $14.30 (+1261.9%) * Over Last 12-Mos
Rating Score: 10 / 10   Percentile Rank: 95%
Date Firm Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
8/31/2021 Cantor Fitzgerald Brandon Folkes New Coverage Overweight
(N/A)		 22.00
(N/A)		 8.59
(1.05)		 -87.78% Details
5/28/2021 WBB Securities Steve Brozak Downgrade Buy
(Strong Buy)		 N/A
(N/A)		 7.14
(1.05)		 -85.29% Details
Like RDHL Ratings? Also take a look at BIOC, MCUR, BABY, VNRX

RDHL Ratings News